Relmada Therapeutics Stock (NASDAQ: RLMD) stock price, news, charts, stock research, profile.
You can purchase shares of Relmada Therapeutics (NASDAQ:RLMD) through any online brokerage.
Other companies in Relmada Therapeutics’s space includes: Cingulate (NASDAQ:CING), Gelteq (NASDAQ:GELS), Kiora Pharmaceuticals (NASDAQ:KPRX), Jaguar Health (NASDAQ:JAGX) and Marinus Pharma (NASDAQ:MRNS).
Relmada Therapeutics has a consensus price target of $15.14.
The stock price for Relmada Therapeutics (NASDAQ: RLMD) is $0.3582 last updated December 24, 2024 at 4:05 PM EST.
There are no upcoming dividends for Relmada Therapeutics.
Relmada Therapeutics’s Q4 earnings are confirmed for Tuesday, March 18, 2025.
There is no upcoming split for Relmada Therapeutics.
Relmada Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.